Publication | Closed Access

nRGD modified lycobetaine and octreotide combination delivery system to overcome multiple barriers and enhance anti-glioma efficacy

Multiple BarriersAnti-glioma EfficacyTranslational MedicineCell-based Drug DeliveryDrug TargetingMedicineDrug Delivery SystemsPharmacotherapyTumor TargetingBiomedical EngineeringPharmacologyGliomaNovel Therapy